Details of the Drug

General Information of Drug (ID: DM9YDPY)

• Drug Name: HB-201

Indication

Disease Entry	ICD 11	Status	REF
Squamous cell carcinoma	2B60-2D01	Phase 1/2	[1]

• Cross-matching ID: TTD ID: DQ2T3S

References

• [1] ClinicalTrials.gov (NCT04180215) A Study of TheraT Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers. U.S. National Institutes of Health.